BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4912291)

  • 1. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
    Brain; 1970; 93(2):357-68. PubMed ID: 4912291
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.
    Johansson B; Roos BE
    Life Sci; 1967 Jul; 6(13):1449-54. PubMed ID: 6035772
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(1):143-8. PubMed ID: 5084388
    [No Abstract]   [Full Text] [Related]  

  • 5. The balance of biogenic amines as condition for normal behaviour.
    Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    J Neural Transm; 1972; 33(2):163-78. PubMed ID: 4643007
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemistry of depression].
    Matussek N
    J Neural Transm; 1972; 33(3):223-34. PubMed ID: 4565920
    [No Abstract]   [Full Text] [Related]  

  • 8. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
    Chase RN; Schnur JA; Brody JA; Gordon EK
    Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
    [No Abstract]   [Full Text] [Related]  

  • 10. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease).
    Gottfires CG; Roos BE
    Acta Psychiatr Scand; 1973; 49(3):257-63. PubMed ID: 4715071
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
    [No Abstract]   [Full Text] [Related]  

  • 12. Amine metabolism in the human brain: further evaluation of the probenecid test.
    Korf J; Van Praag HM
    Brain Res; 1971 Dec; 35(1):221-30. PubMed ID: 5134227
    [No Abstract]   [Full Text] [Related]  

  • 13. Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog.
    Ashcroft GW; Crawford TB; Dow RC; Guldberg HC
    Br J Pharmacol Chemother; 1968 Jul; 33(3):441-56. PubMed ID: 5303853
    [No Abstract]   [Full Text] [Related]  

  • 14. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 16. Amine metabolism in brain.
    Ashcroft GW
    Proc R Soc Med; 1969 Nov; 62(11 Part 1):1099-101. PubMed ID: 5356862
    [No Abstract]   [Full Text] [Related]  

  • 17. Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid.
    Curzon G; Gumpert EJ; Sharpe DM
    Nat New Biol; 1971 Jun; 231(23):189-91. PubMed ID: 5281200
    [No Abstract]   [Full Text] [Related]  

  • 18. Opposite effect of harmaline on seotonin and on dopamine and its metabolites, homovanillic acid and norepinephrine, in the brain of the cat.
    Poirier LJ; Singh P; Boucher R
    Can J Physiol Pharmacol; 1968 Jul; 46(4):585-9. PubMed ID: 5302163
    [No Abstract]   [Full Text] [Related]  

  • 19. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J; Sharpe D; Curzon G
    J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
    [No Abstract]   [Full Text] [Related]  

  • 20. The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
    Papeschi R; Molina-Negro P; Sourkes TL; Erba G
    Neurology; 1972 Nov; 22(11):1151-9. PubMed ID: 4263829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.